Sale!

SOX3 Gene Panhypopituitarism X-Linked NGS Genetic DNA Test

Original price was: $700.Current price is: $500.

-29%

The SOX3 Gene Panhypopituitarism X-Linked NGS Genetic DNA Test is a cutting-edge genetic diagnostic tool that identifies mutations in the SOX3 gene responsible for X-linked panhypopituitarism. This comprehensive test utilizes Next-Generation Sequencing (NGS) technology to detect genetic variations that cause deficiencies in multiple pituitary hormones, affecting growth, metabolism, thyroid function, and reproductive development. The test provides crucial information for accurate diagnosis, personalized treatment planning, and genetic counseling for affected families. At just $500 USD, this advanced genetic analysis offers invaluable insights for individuals with unexplained pituitary hormone deficiencies, growth disorders, or family history of endocrine conditions. Early detection through this test enables proactive management and improved quality of life for patients with complex hormonal imbalances.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

SOX3 Gene Panhypopituitarism X-Linked NGS Genetic DNA Test

Comprehensive Genetic Analysis for Pituitary Hormone Disorders

The SOX3 Gene Panhypopituitarism X-Linked NGS Genetic DNA Test represents a breakthrough in molecular diagnostics for endocrine disorders. This advanced genetic test specifically targets mutations in the SOX3 gene, which plays a critical role in pituitary gland development and function. Panhypopituitarism, characterized by deficiencies in multiple pituitary hormones, can significantly impact growth, metabolism, and overall health when left undiagnosed or improperly managed.

What This Test Measures and Detects

Our comprehensive NGS-based genetic analysis examines the entire SOX3 gene sequence to identify:

  • Point mutations and single nucleotide variations
  • Small insertions and deletions affecting gene function
  • Regulatory region abnormalities impacting gene expression
  • X-linked inheritance patterns specific to SOX3 mutations
  • Genetic variants associated with pituitary hormone deficiencies

The test utilizes state-of-the-art Next-Generation Sequencing technology, providing unparalleled accuracy in detecting even the most subtle genetic variations that traditional methods might miss.

Who Should Consider This Test

This genetic test is particularly recommended for individuals presenting with:

  • Unexplained growth hormone deficiency in childhood or adulthood
  • Multiple pituitary hormone deficiencies affecting thyroid, adrenal, and reproductive functions
  • Family history of X-linked endocrine disorders
  • Developmental delays accompanied by hormonal imbalances
  • Unexplained short stature with associated hormonal abnormalities
  • Suspected genetic forms of hypopituitarism
  • Male patients with pituitary deficiencies and family history suggesting X-linked inheritance

Clinical Benefits of Genetic Testing

Undergoing the SOX3 Gene Panhypopituitarism X-Linked NGS Genetic DNA Test offers numerous advantages:

  • Accurate Diagnosis: Provides definitive genetic confirmation of X-linked panhypopituitarism
  • Personalized Treatment: Enables targeted hormone replacement therapy based on specific genetic findings
  • Family Planning: Offers crucial information for genetic counseling and reproductive decisions
  • Early Intervention: Facilitates proactive management before severe complications develop
  • Comprehensive Care: Guides multidisciplinary approach involving endocrinologists, geneticists, and pediatric specialists
  • Prognostic Information: Helps predict disease progression and potential associated conditions

Understanding Your Test Results

Your genetic test results will be carefully interpreted by our team of certified genetic counselors and endocrinology specialists:

  • Positive Result: Indicates the presence of a pathogenic SOX3 gene mutation, confirming X-linked panhypopituitarism diagnosis
  • Negative Result: Suggests that SOX3 mutations are not the cause of symptoms, guiding further diagnostic evaluation
  • Variant of Uncertain Significance: Identifies genetic changes requiring additional family studies or functional analysis
  • Carrier Status: For female relatives, determines carrier status and inheritance risk assessment

All results include detailed explanations and recommendations for next steps in clinical management.

Test Pricing and Availability

Test Component Price (USD)
Discount Price $500
Regular Price $700
Turnaround Time 3 to 4 Weeks
Sample Type Blood, Extracted DNA, or One Drop Blood on FTA Card

Nationwide Testing Availability

We proudly serve patients across the United States with convenient testing locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more. Our network of certified collection centers ensures accessible genetic testing services nationwide.

Take the Next Step Toward Genetic Clarity

Don’t let unexplained hormonal imbalances or family history of endocrine disorders remain a mystery. Our SOX3 Gene Panhypopituitarism X-Linked NGS Genetic DNA Test provides the answers you need for informed medical decisions and personalized treatment approaches.

Call or WhatsApp us today at +1(267) 388-9828 to schedule your genetic counseling session and book your test. Our dedicated team is ready to guide you through the testing process and help you understand your genetic health.

Remember: Early genetic diagnosis can significantly improve treatment outcomes and quality of life for individuals with pituitary hormone deficiencies. Take control of your endocrine health with comprehensive genetic testing from General Genetics Corporation.